Novavax, Inc. NVV1.F Stock
Novavax, Inc. Price Chart
Novavax, Inc. NVV1.F Financial and Trading Overview
| Novavax, Inc. stock price | 4.19 EUR |
| Previous Close | 7.4 EUR |
| Open | 7.52 EUR |
| Bid | 0 EUR x N/A |
| Ask | 0 EUR x N/A |
| Day's Range | 7.52 - 7.52 EUR |
| 52 Week Range | 5.25 - 75.56 EUR |
| Volume | 10 EUR |
| Avg. Volume | 2.72K EUR |
| Market Cap | 649.36M EUR |
| Beta (5Y Monthly) | 1.711267 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -5.04 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 264.2 EUR |
NVV1.F Valuation Measures
| Enterprise Value | 249.05M EUR |
| Trailing P/E | N/A |
| Forward P/E | 0.23294118 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.4778737 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 0.183 |
| Enterprise Value/EBITDA | -0.219 |
Trading Information
Novavax, Inc. Stock Price History
| Beta (5Y Monthly) | 1.711267 |
| 52-Week Change | -81.087% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 75.56 EUR |
| 52 Week Low | 5.25 EUR |
| 50-Day Moving Average | 7.15 EUR |
| 200-Day Moving Average | 13.69 EUR |
NVV1.F Share Statistics
| Avg. Volume (3 month) | 2.72K EUR |
| Avg. Daily Volume (10-Days) | 1.94K EUR |
| Shares Outstanding | 86.31M |
| Float | 81.46M |
| Short Ratio | N/A |
| % Held by Insiders | 0.44% |
| % Held by Institutions | 61.53% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -85.016% |
| Operating Margin (ttm) | -85.86% |
| Gross Margin | -48.68% |
| EBITDA Margin | -83.56% |
Management Effectiveness
| Return on Assets (ttm) | -33.31% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 1.36B EUR |
| Revenue Per Share (ttm) | 16.86 EUR |
| Quarterly Revenue Growth (yoy) | -88.50% |
| Gross Profit (ttm) | -156045000 EUR |
| EBITDA | -1135463936 EUR |
| Net Income Avi to Common (ttm) | -1155251968 EUR |
| Diluted EPS (ttm) | -13.66 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 624.95M EUR |
| Total Cash Per Share (mrq) | 7.24 EUR |
| Total Debt (mrq) | 246.57M EUR |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.506 |
| Book Value Per Share (mrq) | -10.379 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -653020032 EUR |
| Levered Free Cash Flow (ttm) | -124903504 EUR |
Profile of Novavax, Inc.
| Country | Germany |
| State | MD |
| City | Gaithersburg |
| Address | 21 Firstfield Road |
| ZIP | 20878 |
| Phone | 240 268 2000 |
| Website | https://www.novavax.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 1992 |
Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 and influenza combined. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, Adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also focusing on products candidates for respiratory syncytial virus and malaria. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Q&A For Novavax, Inc. Stock
What is a current NVV1.F stock price?
Novavax, Inc. NVV1.F stock price today per share is 4.19 EUR.
How to purchase Novavax, Inc. stock?
You can buy NVV1.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Novavax, Inc.?
The stock symbol or ticker of Novavax, Inc. is NVV1.F.
Which industry does the Novavax, Inc. company belong to?
The Novavax, Inc. industry is Biotechnology.
How many shares does Novavax, Inc. have in circulation?
The max supply of Novavax, Inc. shares is 139.95M.
What is Novavax, Inc. Price to Earnings Ratio (PE Ratio)?
Novavax, Inc. PE Ratio is now.
What was Novavax, Inc. earnings per share over the trailing 12 months (TTM)?
Novavax, Inc. EPS is -5.04 EUR over the trailing 12 months.
Which sector does the Novavax, Inc. company belong to?
The Novavax, Inc. sector is Healthcare.